Prostate cancer is the most prevalent solid
tumor diagnosed in men in developed countries. The standard treatment for early
stage prostate cancer is surgery (prostatectomy) or radiotherapy. To improve
local control, the radiation dose should be escalated.
Three dimensional
conformal radiation treatment (3DCRT) increases local control rates while
decreasing toxicity rates. Recent data suggest that, to achieve high local
control of prostate cancer with acceptable toxicity, hypofractionated
radiotherapy (HRT) could be used.
Short-duration HRT is an attractive option
compared with a 7-to-8-week course of standard radiotherapy in terms of
logistics; the patient’s job, daily activities, and emotions; the availability
of accelerators, and the cost of prolonged treatment. Quality of life (QoL) has
become one of the most significant issues in treatment decisions in prostate
cancer.
No comments:
Post a Comment